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Abstract
Background: The number of total hip arthroplasties in patients under 30 years is increasing over the years. Almost
all of them will face at least one or more future revisions in their life. Therefore, the implant used should have a
high survival rate, and needs to be easily revisable resulting in a low re-revision rate. Several studies have evaluated
the outcome of total hip arthroplasties in patients under 30 years. However, only a few reported on the follow-up
outcome of 10 years or more. In addition, none of these reports published data of the subsequent revisions of
these implants within their original report.
Methods: We studied historically prospective collected data of 48 consecutive patients (69 hips) younger than
30 years, treated with a cemented primary total hip prosthesis between 1988 and 2004. Since the last evaluation of
this cohort, two patients were lost to follow-up. For all hip revisions in this cohort, again cemented implants were
used, mostly in combination with bone impaction grafting. Kaplan-Meier survival curves at 10- and 15 years for the
primary total hip arthroplasties and revisions were determined.
Results: The mean age at time of primary surgery was 25 years (range, 16 to 29 years). Mean follow-up of the
primary hips was 11.5 years (range, 7 to 23 years). During follow-up 13 revisions were performed; in 3 cases a
two-stage total revision was performed for septic loosening and 9 cups were revised for aseptic loosening. There
were no aseptic stem revisions. The 10 and 15-year survival rates with endpoint revision for aseptic loosening of the
primary total hip were 90% (95% CI: 79 to 96) and 82% (95% CI: 65 to 92) respectively. None of our 13 subsequent
revisions needed a re-revision within 10 years after re-implantation.
Conclusions: Cemented total hip implants in patients under 30 years have an encouraging outcome at 10 and
15 years after surgery in these young patients. The 13 revised hips, treated with bone grafting and the third
generation cement technique, were performing well with no re-revisions within ten years after surgery.
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Background
The number of total hip arthroplasties in very young
patients is rising. Different solutions to treat these young
patients with secondary osteoarthritis have been used
over the last decade. Non-cemented, cemented, hybrids,
metal-on-metal total hip arthroplasties and resurfacing
prostheses all have been used in young patients, with
different success rates [1-22]. Obviously, in these very
young patients it is important to use total hip implants
with a proven long-term outcome [23]. Additionally, we
have to keep in mind that these young people will inevit-
ably face one or more revisions in their life, due to their
longer life expectancy. As a result, the implant used
should have an acceptable and reliable long-term clinical
outcome and it needs to be easy revisable without creat-
ing a bone stock defect. Both survival of the primary
THA and subsequent revision THA are important out-
come measurements in these young patients. So far, only
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a few reports present long-term results of total hip
arthroplasties in patients under 30 years and none
present the outcomes of the first revision THA’s in the
same cohort (Table 1).
Although cemented total hip implants are not com-
monly used in young patients, we have always used
cemented total hips in all ages, including patients
younger than thirty years. Furthermore, we have one es-
sential addition in young patients: in case of substantial
acetabular bone stock deficiencies, we have reconstructed
this bone stock loss using impaction bone grafting (IBG).
In these young patients, secondary osteoarthritis resulting
from underlying diseases is often seen in combination
with associated loss of the acetabular bone stock (e.g. in
developmental dysplasia of the hips and juvenile rheuma-
toid arthritis). This hampers an optimal insertion and fixation
of the cup. We believe that IBG for the reconstruction of
acetabular bone stock deficiencies in young patients is
a biologically attractive approach, which restores bone
stock already before the inevitable future revision [17].
In all revisions we applied the same philosophy of
using IBG on the acetabular side with a cemented cup.
In case of femoral bone stock loss, femoral grafting was
performed as well in order to achieve a durable recon-
struction [24].
The purpose of the current study is to present the clin-
ical and radiographical results of 69 consecutive cemented
total hip arthroplasties in 48 patients less than 30 years
old after a mean follow up of more than 10 years,
reporting the survival data with endpoint revision for any
reason, aseptic loosing and radiological failure. In addition
to the results of the primary total hip arthroplasties, the
current state of our revisions and re-revisions within this
group after the primary total hip arthroplasty will be
assessed. Results will be compared to results of similar or
other techniques found in the literature.
Methods
In 2011, at a minimum follow-up of 7 years (7 to 23 years),
we performed a historical prospective study on 48 con-
secutive patients (69 hips) younger than 30 years, who
received a primary cemented total hip arthroplasty be-
tween April 1988 and May 2004. All indications except
reconstructions for tumors were included. There was no
selection bias as we used cemented total hips in all cases.
The group consisted of 32 female (46 hips) and 16 male
patients (23 hips). The mean age at surgery was 25 years
(range, 16 to 29). Four patients (6 hips) died during
follow-up of causes not related to their hip surgery. The
mean age during surgery of these 4 patients was 24 years
(range, 20 to 26). Their mean follow-up until death was
9 years (range, 1 to 18). None of them was revised be-
fore death and all of them were followed up to their
death on a regular base. Therefore, we included all their
data. Two patients (3 hips) were lost to follow-up since
our first evaluation of this cohort, including one patient
with 2 THA’s after 3.5 years of follow-up of both hips
and one patient with one THA after 11 years [17].
Their data were included in the study up to their latest
clinical and radiographic control. Table 2 lists the
indications for the THA in all patients.
In all cases, a posterolateral approach without a
trochanteric osteotomy was used. Although we used dif-
ferent implants over the years, all of them were fully
cemented (Table 3). All cups were made of conventional
polyethylene and only cobalt-chrome femoral heads of
22 mm (9 hips), 28 mm (49 hips) and 32 mm (11 hips)
were used. Up to 1990, all femoral components were
inserted using a second-generation cementing technique,
while from 1990 onwards the third cementing technique
was used. Palacos cement was used until 1989 (Merck,
Darmstadt, Germany); from 1989 on we used Surgical
Simplex (Stryker-Howmedica, Newburry, UK). Antibiotics
Table 1 Characteristics and survivorship of THA in patients 30 years or younger at time of operation with a mean
follow-up of more than ten years in literature up to March 2011
Study No hips No
patients
Mean age in years
(range)
Mean follow-up in years
(range)
Survivorship/revised hips for all
reasons
Cemented
Cage et al. [4] 29 17* 18.4 (15–21) 10.6 (8–15) 1 revision at 11 yrs
Chmel et al. [7] 66 39 19.9 (11–29) 15.1 (11–22) 70% at 15 yrs (acetabular revision)
Sochart and Porter [8] 83 55 24.9 (17–29) 20 (5–30) 89% at 10 yrs ; 65% at 25 yrs
Torchia et al. [6] 63 50 17 (11–19) 12.6 (1.6-18.6) 27 revisions#
Witt et al. [3] 96 54 16.7 (11–27) 11.5 (5–18) 24 (25%) at average 9.5 years follow-up
Wroblewski et al. [18] 39 28 17.9 (12–19) 12.6 (2.3 – 29.0) for non-revision 16 revisions at mean 19.1 yrs (8–34)
(current study) 69 48 24.6 (16–29) 11.3 (2–23.4) 86% at 10 yrs; 75% at 15 yrs
Uncemented
Wangen et al. [16] 49 44 25 (15–30) 13 (10–16) 24 revisions of acetabular component#
*mixed group of patients with total hip and total knee prosthesis.
#at mean follow-up.
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(cefazolin) were given during a maximum of 24 hours
postoperatively to prevent infections.
In case of bone stock deficiency during the primary
procedure, we used the IBG technique to reconstruct
acetabular defects (29 hips) (Figure 1 and 2). This tech-
nique has been described in the literature in detail be-
fore [17,25]. Acetabular defects were classified according
to the classification system of the American Academy of
Orthopaedic Surgeons (AAOS) Committee on the Hip
[26]. In 5 hips a Type I defect was present. A Type II de-
fect was seen in 16 hips and a Type III defect in 8 hips.
In 23 hips, femoral head autografts were used, whereas
fresh-frozen nonirradiated femoral head allografts were
used as a source for bone chips in 3 hips with a Type III
defect. In another 3 hips, both autografts and a fresh
frozen allograft femoral head were used.
Postoperatively, patients were treated with subcutane-
ous low-molecular-weight heparin for 6 weeks. Before
1999, oral anticoagulants were prescribed for 3 months
according to our previous postoperative protocol. Indo-
methacin was administered for 7 days to prevent
heterotopic ossification. Alternatively, one dose (7 Gy)
of radiotherapy was given, when indomethacin was
contraindicated. Patients without a defect or a simple
minor cavitary defect were mobilized under the super-
vision of a physiotherapist two days after surgery. In
case of extended reconstructions, 10% touch weight
bearing with crutches was allowed for 6 weeks, followed
by 50% touch weight bearing for another 6 weeks, be-
fore full weight bearing was allowed. In case of very
extensive acetabular reconstructions, e.g. severe pelvic
dislocation and high dislocation, patients initially had a
six-week period of bed rest to achieve full graft incorp-
oration before starting mobilization.
The antero-posterior pelvic and lateral hip radiographs
of all hips were analysed on a consensus basis by two of
the authors (MWJLS and BWS). Follow-up radiographs
were complete for all hips, except for the two patients
lost to follow-up. Graft incorporation was determined as
the manifestation of a regular radiodensity and trabecu-
lar bone structure throughout the graft and host bone
with a continuous trabecular pattern according to Conn
et al. [27]. Radiolucent lines were described if they were
more than 2 mm wide and were defined as stable or as
progressive lines in time. The criteria of DeLee and
Charnley were used to identify acetabular zones [28].
Radiographic failure was defined as radiolucent lines in
all three zones and/or migration of 5 mm or more in
any direction on the AP-pelvic view relative to the
interteardrop line. The classification of Brooker et al. was
used to describe heterotopic ossification [29]. Polyethylene
wear was calculated using the method of Dorr and Wan
[30]. On the femoral side, the Gruen classification was used
to determine radiolucent zones [31]. Femoral prosthetic
subsidence was considered if it was more than 2 mm [32]
while definite loosening of the stem was defined as the
appearance of a radiolucent line in all Gruen zones that
did not exist on the immediate postoperative radiographs,
or as a crack in the cement or fracture of the stem [33].
The Harris Hip Score and Oxford Hip Score were
determined at each follow-up visit to evaluate clinical
results, as were the VAS scores (on a scale of 1 to 100) for
pain during rest and activity as well as the VAS score for
satisfaction about the hip function (on a scale of 1 to 100).
Table 2 Indication for total hip arthroplasty (n = 69)
Indication Number of
hips
Juvenile rheumatoid arthritis 18
Osteonecrosis of femoral head 21
Systemic lupus erythematosus 7
Acute lymphatic leukemia 3
Crohn’s disease 3
Nepropathy, kidney transplantation 2
Hypothalamic disorder 1
Aplastic anemia 1
Wegener’s disease 1
Unknown origin 3
Developmental dysplasia of the hip 7
Multiple epiphyseal dysplasia 2
Legg-Calvé-Perthes disease 6
Ankylosing spondylitis 5
Morquio’s disease 2
Ankylosis of unknown origin 2
Polycystic disease of the femoral head of unknown
origin
2
Arthritis and osteomyelitits 2
Posttraumatic osteoarthritis 1
Psoriatic arthritis 1
Table 3 Types of implant
Type of acetabular implant Number of hips Type of femoral implant Number of hips
MüllerW/AlloproW cup 14 M.E. MüllerW straight stem 11
Elite™ Plus LPW 26 Charnley Elite (Plus) stem™ 13
Exeter/Contemporary™ 29 Exeter Stem™ 45
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Cemented total hip arthroplasties with acetabular IBG
were used in al revision procedures. In case of femoral
bone deficiency, we performed femoral IBG [34].
For this study, no ethical approval was required by the
local ethical committee.
Statistical analysis
Kaplan-Meier survival analysis were used to determine
the survivorship of the primary hip implant for the
endpoints revision of one or both components for 1) any
reason, 2) aseptic loosening and 3) radiographic failure.
In addition to analysis for the total group, hips with and
without acetabular IBG were also analysed separately. The
HHS and OHQS were evaluated in 3 categories: 1) after 2
to 5 years follow-up, 2) after 5 to 10 years follow-up and
3) after more than 10 years follow-up. A ‘last observation
carried forward analysis’ was done to determine the mean
HHS and OHQS scores for the total group of surviving
hips. VAS scores regarding pain in rest, pain during activ-
ity and overall satisfaction were determined. In addition to
the results of our primary total hip arthroplasties, a
Kaplan-Meier survival analysis was performed for the
revisions in our group. HHS and OHQS, as well as VAS-
scores were also calculated for the revised total hip
arthroplasties. All calculations were made with SPSS
18.0.2 and SAS for Windows 9.2.
Results
Clinical results
Mean duration of follow-up of all 69 primary total hips
was 11.5 years (range, 7 to 23 years). During follow-up,
5 patients died (7 hips), two patients were lost to
follow-up (3 hips) and 13 hips were revised for several
reasons. The average pre-operative HHS score was
47.0 (range 15 to 81) (n = 30), and the average pre-
operative OHQS was 43.2 (range 34 to 52) (n = 9). At
review the mean HHS of the 49 surviving hips was
88.3 (n = 48) (range 55 to 100) and the mean OHQS
was 17.5 (range, 12 to 34) (n = 49) after a mean follow-
up of 11.6 (range 3.0 to 22.0). The mean VAS score for
pain in rest and during activity on a scale from 0–100
after a mean follow-up of twelve years were 5.5 and
Figure 1 In 29 of the 69 cases, a pre-operative bone stock deficiency on the acetabular side was present, which was classified
according to the AAOS classification and treated with a cemented THA and IBG.
Figure 2 Acetabular reconstruction in a 27-year-old woman with secondary osteoarthritis due to congenital hip dysplasia. Preoperative
(A), immediately postoperative (B), and 12 years postoperative (C).
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16.0, respectively. VAS score for overall satisfaction
was 88.8.
Revisions and complications
Three total revisions for septic loosening were performed
at 4.8, 5.7 and 6.1 years after the index surgery. All
were treated with a two stage treatment protocol and
all components were exchanged. One patient, originally
planned for a one-stage cup revision after 13 years for
aseptic loosening had positive cultures at revision,
suggesting septic loosening. This patient was treated
during 3 months with antibiotics and despite partial re-
vision, no relapse occurred. Nine cups had been revised
because of aseptic loosening at 2.3, 3.0, 4.1, 4.9, 7.6, 8.6,
13.6, 14.3 and 23.6 years. Except for the three stems
revised for septic loosening, no additional stems had
failed. One highly polished stem had to be exchanged
for a same size stem using the cement in cement tech-
nique during a cup revision due to damage to the taper
caused during that cup revision. This case was scored as a
re-operation but this stem exchange is not considered as a
stem failure.
In addition to these revisions mentioned, one early re-
operation after a primary THA was necessary due to a
suspected infection. The patient recovered after débride-
ment and antibiotic therapy without implant revision.
Two early dislocations were seen. In one case an open
reduction was needed. One partial femoral nerve deficit
was seen, and despite surgical release, recovery was
incomplete. One periprosthetic fracture, type Vancouver
B1 occured, fifteen years after the primary surgery for
which open reduction and internal fixation was necessary
without exchange of the implant. Other complications
and their outcomes are listed in Table 4.
Radiographic results
Radiolucent lines around the cup were observed in 18 of
the 56 surviving hips, which were progressive in 6 hips.
Osteolysis was seen in different zones on the acetabular
side as well as on the femoral side. The complete detailed
radiographic characteristics found in the 56 non-revised
total hip arthroplasties are shown in Table 5.
Survivorship analysis
Regarding the endpoint revision for any reason of both
cup and stem, the 10-year survival rate for the primary
total group was 86% (95% CI: 74 to 92 ) and the 15-year
survival rate was 75% (95% CI: 59 to 86) (Table 5). For
endpoint revision for aseptic loosening, the 10- and
15-year survival rates for the total group were 90%
(95% CI: 79 to 96) and 82% (95% CI: 65 to 92), respectively
Table 4 Complications of the 69 primary total hip
arthroplasties, excluding the 13 revisions
Complications N Outcome
Early reoperation due to
suspicion of deep infection
1 Fully recovered
Dislocation 2 One successful closed reduction,
however one dislocation in a multi
trauma patient needed surgical
reduction
Neurological deficit 1 Femoral nerve exploration→
incomplete recovery
Periprosthetic Fracture
Vancouver B1
1 Plate osteosynthesis with cable grip
plate system. No revision of the
implant
Table 5 Radiographic characteristics of 56 primary total
hip arthroplasty patients that were not revised at last
follow-up
Radiographic characteristics
Acetabular radiolucent lines 18
Progressive 6
Stable 12
Osteolysis 9
Zone I 3
Zone II 3
Zone III 2
Zone I + II 1
Socket migration -
Progressive tilting of the cup -
PAO’s 13
Brooker class II 9
Brooker class III 4
Polyethelyne wear > 2 mm 3
Femoral radiolucent lines 3
Zone 7 1
Zone 3 and 5 1
6 out of 7 zones 1
Rounding off of the calcar 8
Cortical atrophy 2
Zone 4 1
Zone 7 1
Cortical hypertrophy 5
Zone 3 1
Zone 4 3
Zone 5 1
Osteolysis of femoral component 7
Zone 1 1
Zone 4 1
Zone 5 1
Zone 7 1
Zone 1 and 7 4
Note: multiple radiographic characteristics per patient are possible.
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(Table 6 and Figure 3). Of the 9 revisions for aseptic
loosening, 7 were primary cemented hips without IBG
while there were only 2 revisions in the IBG group. The
15-year survival rate for the primary cemented hips was
80% (95% CI: 60 to 91) for endpoint aseptic loosening,
whereas this was 86% (95% CI: 48 to 97) for the total hips
that were combined with IBG group. This was not
statistically different (p = 0.30). Survival curves for each
type of implant separately did not show any significant
differences.
Outcome of the thirteen revisions
All 13 failed primary hips were revised in our institution
and the reasons for revision have been explained previously.
In all 3 septic loosenings, acetabular bone impaction
grafting and a cemented implant was used in the second
stage. Additionally, in 2 of the stem revisions femoral bone
impaction grafting was used. No relapse of infection oc-
curred. In the 9 isolated cup revisions, acetabular bone im-
paction was used in combination with a cemented cup. In
one case the new cup was simply re-cemented. The 12
defects seen on the acetabular side were five segmental
defects (AAOS type I), two cavitary defects (AAOS type II)
and five combined defects (AAOS type III). All of the seg-
mental defects were reconstructed using a wire mesh. Of
the cavitary defects, one did not need any mesh while the
other was reconstructed with a medial and a rim mesh. Of
the combined defects, 2 received only a rim mesh and three
received both a rim and a medial mesh. The mean follow-
up of the 13 revisions after the surgery was seven years
(range, 1 to 15 years). Remarkably, the only re-revision in
this study was performed 13 years after cup revision with-
out acetabular bone impaction grafting. One patient had a
partial lesion of the femoral nerve after a cup revision,
which recovered partially without any invasive treatment.
Of the twelve non re-revised cups, we collected the
postoperative HHS and OHQS after a mean follow-up of
7 years (range, 0.5 to fifteen years), which were 82.7
(range 49 to 100) and 22.3 (range 12 to 52), respectively.
Further analysis of these scores revealed that two
patients had strikingly disappointing HHS and OHQS
scores. One of the patients has a history of sclerodermia,
M. Crohn, and recently received a stoma. The second
patient post-operatively experienced problems of the
femoral nerve which influences his activity and pain
scores. This explains the differences of the HHS and
OHQS scores between the primary and revision total
hip arthroplasties. VAS scores of the twelve patients
after revision for pain during rest and activity were 11.7
(range, 0–80) and 36.7 (range, 0 to 100), respectively.
The mean VAS satisfaction score was 68.3 (0 to 100).
The Kaplan Meier survival curve of our revisions with
endpoint revision for any reason showed a 100% survival
at 10 years.
Discussion
Very young patients with osteoarthritis of the hip are
still a challenge for orthopaedic surgeons. Frequently,
due to the underlying pathology, an acetabular bone
stock deficiency in this group is seen. Often large sized
cups are used in order to cover this defect, without re-
storing the bone stock. However, in these younger THA
patients, future revisions will be inevitable. It is therefore
of extreme importance to create an optimal bone stock
situation in order to prepare future (re)-revisions. We
have described both the technique and outcome of the
reconstruction of acetabular defects with IBG in young
patients up to the age of 50 before [25,35,36].
Table 6 The 10-year and 15-years survivorship with the 95% confidence intervals (CI) for the three endpoints (revision
for any reason, revision for aseptic loosening, radiographic failure) of the 69 hips including 29 total hip arthroplasties
with impaction bone grafting (IBG) and 40 primary cemented total hip arthroplasties
Category of patients Proportion revision free for any
reason
Proportion revisions free for
aseptic loosening
Proportion free of radiographic
failure
10-year (95% CI) 15-year (95% CI) 10-year (95% CI) 15-year (95% CI) 10-year (95% CI) 15-year (95% CI)
All hips (n = 69) 86% (74 to 92) 75% (59 to 86) 90% (79 to 96) 82% (65 to 92) 90% (80 to 96) 82% (65 to 92)
Primary cemented hips (n = 40) 81% (64 to 91) 71% (50 to 84) 86% (70 to 94) 80% (60 to 91) 86% (70 to 94) 80% (60 to 91)
Acetabular IBG (n = 29) 93% (74 to 98) 83% (49 to 95) 96% (77 to 99) 86% (48 to 97) 96% (77 to 99) 86% (48 to 97)
Figure 3 Kaplan Meier estimated survival of the total of sixty-
nine hips regarding endpoint revision for aseptic loosening.
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Although it is not very common in young patients, we
have always used cemented total hip arthroplasties and
cemented revisions in this young population. Further-
more, we used bone grafts in all cases with bone stock
loss, thereby facilitating a biological reconstruction. Our
10 year Kaplan Meier estimated survival for endpoint
aseptic loosening of 90% (95% CI: 79 to 96) is within the
NICE criteria [37]. Our 15 year estimated survival of
82% is still acceptable in these very young patients but
needs to be monitored closely over the next years.
At review of the literature in March 2011, there was
only limited literature available regarding the survival
and complications of a total hip arthroplasty after a
mean follow-up of 10 years or more in patients under
30 years. None of the reports included the outcome of
their revisions in the same report as well. It should be
noted that for young patients both outcome of the pri-
mary and revision THA, are equally important. More-
over, we assume that the outcome of the revision THA
can be influenced by the primary THA procedure. Our
results are at least comparable to the cohorts treated
with a cemented THA, mentioned in Table 1. Compared
to the studies reporting on cohorts of the same size
there seems to be a trend that the survival rates we ob-
tain by using the biological IBG technique are more
favourable, as can be seen in Table 1. For the non-
cemented total hip arthroplasty, only Wangen et al. [16]
reported the survival rates in patients less than 30 years
old after a mean follow-up of more than 10 years. They
reported 24 acetabular revisions in 49 hips at a mean
follow-up of 13 years. McCullough et al. reported the
survival rates in patients with a mean age of 24 years
(range, 11 to 35) and showed a survival rate for the
THA of 71% at 13 years [13]. Both these studies do not
equal our satisfying long-term survival rates. Over time,
other techniques like the resurfacing prosthesis and large
head metal-on-metal THA, have been introduced to
treat young people with osteoarthritis. Unfortunately,
the resurfacing prosthesis has shown its limitations, even
before a large number of long-term follow-up studies
were finished [38]. A higher revision risk for younger fe-
male patients is observed, possibly related to their lower
neck-head ratio, restricting the indications to younger
males [39]. Furthermore, the formation of pseudotumors
and elevated ion levels which have been described for
large head Metal-on-Metal THA as well, cause limitations
to the application of these types of arthroplasties [40].
The study of Girard et al. shows a very acceptable
10-year survival rate of 94.5% (95% CI: 80 to 98.6) for
the non-cemented total hip arthroplasty with metal-on
-metal bearings in patients younger than 30 years at
time of surgery, but includes only 28 mm heads [22].
In our study we observed 13 revisions. Reasons for
failure, in addition to the 4 septic revisions (3 complete
revisions and one cup revision), are speculative and
probably multifactorial. Two of our aseptic failures
experienced a fall that could have caused accelerated
loosening.
One cup that was part of a total hip arthroplasty revision
for septic loosening performed thirteen years earlier was
re-revised. All other twelve revised hips were reconstructed
on the acetabular side with IBG. All of them are still in situ
and none of them show radiographic loosening. No
femoral revisions for aseptic loosening were performed,
emphasizing the good results of the cemented femoral
component in this specific young population. The 100%
survival of our revisions at ten-year follow-up is a
promising result for young people. The outcome of the
primary prosthesis and the subsequent revision out-
come are equally important to determine the best solu-
tion in young patients.
IBG was associated with attractive survival results both
in primary THA and revisions. Of the 9 primary total
hip arthroplasties that needed a revision for aseptic
loosening, only 2 had received IBG. The results as
shown in Table 5 clearly outpoint a trend that IBG
shows better results compared to non-IBG. Even after
15 years of follow-up, the survival rate for endpoint revi-
sion for any reason is still 83% (95% CI: 49 to 95) and
for aseptic loosening even 86% (CI: 48 to 97).
The number of hips in this study is acceptable with a
regarding the longterm follow-up. In addition, the out-
come of all revisions is known. In all patients, the same
philosophy was used. As a referral centre we have
included all indications except oncologic cases, which
makes this an unique cohort. However, this study has
some limitations. First, two patients were lost to follow-
up. Often patients lost to follow-up are presented as
censored cases. But as described by Murray, this might
underestimate the revision rate [41]. Secondly, several
different implants are used in our relatively small group
of patients, however, all were cemented and all patients
were treated in the same way according to our protocol.
Survival curves for each type of implant separately
showed no significant differences, and two of the
components are still widely used (Exeter and Müller,
Table 2) [42]. Furthermore, when reporting on surgery
performed over a period of time, the use of different
implants is almost inevitable. One can argue that 26 of
our patients were treated for rheumatic diseases and
therefore may be low-demand patients. However, most
series on hip arthroplasty outcome in very young
patients include a significant number of patients with
rheumatic disease. Lastly, it would be interesting to have
more information about the activity level of all patients
in addition to the collected HHS, OHS and VAS scores,
as these scores might not completely satisfactorily
describe level and duration for sport activity etc. In
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addition, as this study is performed in a consecutive
series of 69 THA’s performed in the period 1988–2004 it
is not possible to retrospectively collect more informa-
tion about the difference in pre- and postoperative activ-
ity level.
Conclusions
The 10- and 15 year survival rates for endpoint aseptic
loosening of cemented total hip arthroplasty in patients
younger than 30 years are promising and indicate that
this is a satisfying option for young people suffering of
degenerative cartilage disease. IBG can be used to recon-
struct the acetabular bone deficiency in primary as well
as revision total hip arthroplasty. In our cohort none of
the subsequent revisions was revised within 10 years.
Particularly for young patients, reporting the survival of
primary total hip arthroplasties and reporting the sur-
vival results of the revisions of the same cohort are
equally important.
The study was performed in accordance with the ethical
standards in the Helsinki Declaration of 1975, as
revised in 2000. The study has been carried out in the
Netherlands in accordance with the applicable rules
concerning the review of research ethics committees and
informed consent and does not need any further ethical
approval.
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